xbi 破位下跌的原因是穿普也要學希拉裏，打壓藥價

President-elect Trump's biotech comments sharply lower biotech ETFs

 

President-elect Trump's biotech comments sharply lower biotech ETFs President-elect Trump's biotech comments sharply lower biotech ETFs SPDR S&P Biotech ETF XBI XBI, -3.62% slumped 1.9% and iShares NASDAQ Biotech ETF IBB IBB, -3.10% sunk 1.8% in pre-market trade on Wednesday after President-elect Donald Trump's Time cover story quoted the celebrity businessman saying "I'm going to bring down drug prices. I don't like what has happened with drug prices." Biotech has experienced an unprecedented rally over the last month on investors' relief at former Democratic presidential candidate Hillary Clinton's loss. Clinton had repeatedly called for regulation of the pharmaceutical industry. XBI rose 12.3% over the last month, and IBB rose 5%, compared with a 3.8% rise in the S&P 500 SPX, +0.06% "Everybody" was cautious about biotech investments before the election, Andrew McDonald, co-portfolio manager of biotech ETFs BBC BBC, -3.98% and BBP BBP, -3.61% told MarketWatch in mid-November. But now, "it's just getting started. Most people aren't sure this is real...but we've just taken 90% of the risks in the sector away."

如果你目前沒有xbi，ibb倉位，還是觀望為好。開盤後ibb，xbi已經回踩了各自的關鍵支持點，有小反彈，看目前形勢有要再次去試一次那個支持點的跡象。YMYD